Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.

Aromatase inhibitors are the standard adjuvant hormone therapy for postmenopausal women with hormone-sensitive breast cancer.

Sharib Hashmi opens up on wife Nasreen Hashmi's cancer relapse, the mental and financial toll it has taken on him and how he ...

A mother’s cross-country trip, an experimental drug and a teen refusing to give up: Inside one family’s fight against ...

AstraZeneca said on Thursday that a late-stage trial of Imfinzi, combined with ​a targeted therapy prior to a ‌surgery, ...

SHREVEPORT, La. - Patients diagnosed with liver cancer in the ArkLaTex now have access to a new treatment option closer to ...

A Twin Cities teenager is facing an unimaginable battle: terminal cancer. She's fortunate enough to have family by her side ...

As someone who doesn’t do well with the recovery downtime that comes with recovering from surgery, Caroline McCarty was happy to have an option for her ovarian cancer surgery that had a faster ...

Catherine, Princess of Wales, has arrived in Italy on her first official overseas trip since being treated for cancer. She's ...

A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for ...

Only about 10% to 15% of patients with this type of brain cancer survive up to 2 years. An adjuvant personalized DNA vaccine ...

A personalized DNA vaccine for glioblastoma, an aggressive and incurable brain cancer, appears safe and shows early signs of ...